Showing results (211-220 of 226) with videos related to
Sort By:
Pageof 23
Thyroid : Official Journal of the American Thyroid Association|October 10, 2019
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid CancerAshish V Chintakuntlawar, Jun Yin, Robert L Foote, et al.Cancers|January 23, 2024
Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck TumorsRobert L Foote, W Scott Harmsen, Adam C Amundson, et al.International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell CarcinomaDavid M Routman, Sunil Kumar, Bisham S Chera, et al.Plos One|February 23, 2010
Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterationsBrian B Tuch, Rebecca R Laborde, Xing Xu, et al.International Journal of Radiation Oncology, Biology, Physics|December 28, 2020
Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the OropharynxMark R Waddle, Daniel J Ma, Sue L Visscher, et al.Oral Oncology|September 17, 2023
Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated diseaseKathleen R Bartemes, Benjamin R Gochanour, David M Routman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2019
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell CarcinomaDaniel J Ma, Katharine A Price, Eric J Moore, et al.International Journal of Radiation Oncology, Biology, Physics|October 29, 2022
A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer PatientsJustin D Anderson, Todd A DeWees, Daniel J Ma, et al.JAMA Otolaryngology-- Head & Neck Surgery|May 22, 2025
ctDNA and Recurrence Risk for Adjuvant De-Escalation in HPV-Positive Oropharyngeal Carcinoma: A Secondary Analysis of the DART Phase 3 Randomized Clinical TrialDavid M Routman, Kathryn M Van Abel, Katharine A Price, et al.Oral Oncology|September 21, 2023
Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary centerChadi N Abdel-Halim, Thomas J O'Byrne, Jeffrey P Graves, et al.Pageof 23